Stock listing

KRX:185490 EyeGene, Inc. (아이진) 주가

Follow EyeGene, Inc. into a list and get an email when it puts out news.

Share price · KRX:185490

₩1,720.00 KRW +18.00 (+1.1%)

Close on Nov 20, 2026

Past year -2.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩1,720.00 – ₩1,789.00 KRWNov 20, 2026
Volume
35,817 sharesNov 20, 2026
Market cap
₩74.34B KRWAt the close on Nov 20, 2026 · price × 43.22M shares outstanding
52-week range
₩1,182.00 – ₩2,805.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩206.8M KRWMedian day 63,542 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
EyeGene, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:185490 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩1,720.00+18.00+1.1%₩1,759.00₩1,789.00₩1,720.0035,817
₩1,702.00-7.00-0.4%₩1,726.00₩1,726.00₩1,620.0048,834
₩1,709.00-10.00-0.6%₩1,786.00₩1,786.00₩1,640.0028,377
₩1,719.00+1.00+0.1%₩1,718.00₩1,797.00₩1,708.0025,331
₩1,718.00-37.00-2.1%₩1,779.00₩1,812.00₩1,715.0039,093
₩1,755.00-14.00-0.8%₩1,780.00₩1,780.00₩1,712.0039,753
₩1,769.00+25.00+1.4%₩1,715.00₩1,793.00₩1,715.0041,220
₩1,744.00+39.00+2.3%₩1,706.00₩1,799.00₩1,701.0049,684
₩1,705.00-15.00-0.9%₩1,700.00₩1,773.00₩1,700.0067,640
₩1,720.00+28.00+1.7%₩1,699.00₩1,730.00₩1,610.0073,998
₩1,692.000.000.0%₩1,772.00₩1,772.00₩1,680.0028,001
₩1,692.00-21.00-1.2%₩1,713.00₩1,788.00₩1,621.0083,995
₩1,713.00-31.00-1.8%₩1,740.00₩1,769.00₩1,685.0048,541
₩1,744.00+39.00+2.3%₩1,651.00₩1,770.00₩1,651.0036,580
₩1,705.00-45.00-2.6%₩1,762.00₩1,762.00₩1,696.0037,258
₩1,750.00+33.00+1.9%₩1,717.00₩1,797.00₩1,698.0041,962
₩1,717.00-32.00-1.8%₩1,749.00₩1,749.00₩1,686.00194,805
₩1,749.00+69.00+4.1%₩1,680.00₩1,800.00₩1,675.0052,408
₩1,680.00-123.00-6.8%₩1,730.00₩1,877.00₩1,670.00101,257
₩1,803.00-62.00-3.3%₩1,894.00₩1,895.00₩1,700.0056,597
₩1,865.00-85.00-4.4%₩1,930.00₩1,949.00₩1,865.0044,680
₩1,950.00+14.00+0.7%₩1,935.00₩1,960.00₩1,905.0080,823
₩1,936.00-33.00-1.7%₩1,970.00₩1,970.00₩1,903.0022,778
₩1,969.00+18.00+0.9%₩1,950.00₩1,980.00₩1,932.0039,457
₩1,951.00+125.00+6.8%₩1,844.00₩1,965.00₩1,843.00123,105
₩1,826.00-65.00-3.4%₩1,830.00₩1,900.00₩1,801.0099,041
₩1,891.00+52.00+2.8%₩1,894.00₩1,906.00₩1,851.0083,788
₩1,839.00-42.00-2.2%₩1,855.00₩1,881.00₩1,825.0086,954
₩1,881.00+11.00+0.6%₩1,889.00₩1,929.00₩1,855.0030,496
₩1,870.00-9.00-0.5%₩1,879.00₩1,903.00₩1,854.0054,245
₩1,879.00+1.00+0.1%₩1,897.00₩1,905.00₩1,866.0043,238
₩1,878.00-40.00-2.1%₩1,917.00₩1,927.00₩1,877.0070,839
₩1,918.00-51.00-2.6%₩1,966.00₩1,973.00₩1,870.00104,615
₩1,969.00+34.00+1.8%₩1,988.00₩1,988.00₩1,921.0039,046
₩1,935.00+12.00+0.6%₩1,930.00₩1,987.00₩1,922.0044,457
₩1,923.00-27.00-1.4%₩1,994.00₩1,994.00₩1,919.0042,837
₩1,950.000.000.0%₩1,930.00₩1,995.00₩1,927.0027,646
₩1,950.00+20.00+1.0%₩1,930.00₩1,960.00₩1,925.0035,327
₩1,930.00-35.00-1.8%₩1,965.00₩1,985.00₩1,915.0065,480
₩1,965.00+34.00+1.8%₩1,960.00₩1,985.00₩1,900.0079,073
₩1,931.00+7.00+0.4%₩1,924.00₩1,964.00₩1,890.0050,133
₩1,924.00+18.00+0.9%₩1,906.00₩1,959.00₩1,902.0047,971
₩1,906.00-94.00-4.7%₩2,000.00₩2,015.00₩1,891.00120,285
₩2,000.00-10.00-0.5%₩2,000.00₩2,050.00₩1,978.0086,495
₩2,010.00-140.00-6.5%₩2,150.00₩2,205.00₩1,997.00227,974
₩2,150.00+85.00+4.1%₩2,020.00₩2,220.00₩2,020.00227,502
₩2,065.00-40.00-1.9%₩2,110.00₩2,145.00₩2,040.0061,603
₩2,105.00+15.00+0.7%₩2,095.00₩2,135.00₩2,035.00108,591
₩2,090.00+70.00+3.5%₩2,020.00₩2,165.00₩2,020.00198,902
₩2,020.00+30.00+1.5%₩1,990.00₩2,075.00₩1,974.00100,647
₩1,990.00+50.00+2.6%₩1,936.00₩2,005.00₩1,935.00105,383
₩1,940.00+14.00+0.7%₩1,926.00₩1,959.00₩1,905.00106,541
₩1,926.00+22.00+1.2%₩1,899.00₩1,976.00₩1,891.00146,828
₩1,904.00-4.00-0.2%₩1,910.00₩1,947.00₩1,885.00114,747
₩1,908.00-12.00-0.6%₩1,942.00₩1,954.00₩1,881.0099,273
₩1,920.00+63.00+3.4%₩1,857.00₩1,939.00₩1,852.00113,200
₩1,857.00-11.00-0.6%₩1,853.00₩1,893.00₩1,842.0043,771
₩1,868.00+22.00+1.2%₩1,934.00₩1,934.00₩1,845.0043,971
₩1,846.00-54.00-2.8%₩1,900.00₩1,900.00₩1,779.00147,905
₩1,900.00+28.00+1.5%₩1,950.00₩2,150.00₩1,874.00434,256
₩1,872.00-153.00-7.6%₩1,970.00₩1,995.00₩1,831.00267,058
₩2,025.00+210.00+11.6%₩2,305.00₩2,305.00₩1,955.001,456,764

Splits

2 splits since 2021 · KRX:185490 · every price before a split is adjusted for it

DayRatioWhat
111-for-95Split
12-for-11Split
Ticker
KRX:185490
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

EyeGene, Inc. on 6ix

Sector
Health care
Industry
Biotechnology

Valuation

EV/sales 8.0× against a median of 143×: the lowest of 5 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩35.67B KRW
P/E
Loss
EV/sales
8.0×
EV/EBITDA
Negative EBITDA
Price/book
1.5×
Gross margin
27.8%
Operating margin
−276.2%
Net margin
−391.5%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
EyeGene, Inc. · KRX:185490US$55.57MUS$26.66Mn/a8.0×n/a1.5×−391.5%0.0×n/a
Tenax Therapeutics, Inc. · NASDAQ:TENXUS$56.92M−US$56.78Mn/an/an/a0.5×n/a0.0×1.35
Kazia Therapeutics Ltd · NASDAQ:KZIAUS$56.22MUS$10.36Mn/a373×n/a1.8×n/a0.0×2.31
OKYO Pharma Limited · NASDAQ:OKYOUS$56.15MUS$35.56Mn/an/an/a4.5×n/a0.0×1.02
Gwo Xi Stem Cell Applied Technology Co., Ltd. · TPEX:6704US$55.77MUS$51.65Mn/a9.1×n/a2.5×−43.0%0.3×n/a
Cognition Therapeutics, Inc. · NASDAQ:CGTXUS$55.37MUS$25.10Mn/an/an/a1.9×n/a0.0×2.28
AB Science SA · EURONEXT:ABUS$55.19MUS$50.54Mn/a39.2×n/an/a−132.6%n/an/a
Azora Therapeutics, Inc. · NASDAQ:AZRUS$55.00MUS$33.00Mn/an/an/an/an/an/a1.00
Island Pharmaceuticals Ltd · ASX:ILAUS$54.84MUS$46.32Mn/a248×n/a6.2×n/a0.0×n/a
Anavex Life Sciences Corp. · NASDAQ:AVXLUS$54.83M−US$63.50Mn/an/an/a0.5×n/a0.0×2.39
Nordicus Partners Corp · OTC:NORDUS$54.44MUS$54.44Mn/an/an/a0.9×n/a0.0×0.45
Median of the othersUS$55.28MUS$34.28M143×1.9×−87.8%0.0×1.35

Events

QuarterResultsShare move
Q4 2023Feb 20, 2024 · Before open+1.3%
Quarter to Dec 31, 2020Feb 24, 2021 · Before open−3.3%

Open Events

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.57B3.36B3.13B5.29B3.24B3.36B4.25B2.04B301.0M267.2M
Cost of revenue2.45B2.20B1.24B2.55B1.74B1.81B2.31B1.27B203.7M68.6M
Gross profit1.12B1.16B1.89B2.75B1.50B1.55B1.94B761.9M97.4M198.7M
Research and development5.92B8.27B20.4B16.3B28.0B8.82B5.10B3.78B5.05B4.69B
Selling, general and administrative1.83B5.57B7.82B10.0B8.05B5.55B5.49B4.80B3.92B4.00B
Operating income-9.85B-13.3B-27.2B-23.6B-36.9B-14.0B-9.56B-8.27B-9.29B-8.59B
Depreciation and amortization2.08B2.34B2.08B1.29B1.07B853.3M703.2M442.5M387.1M145.7M
EBITDA-7.77B-10.9B-25.1B-22.3B-35.8B-13.2B-8.86B-7.82B-8.91B-8.45B
Interest expense628.6M699.0M462.6M395.3M1.75B2.52B0000
Income before tax-19.1B-12.9B-22.4B-27.7B-34.7B-15.3B-8.74B-7.19B-8.81B-8.27B
Income tax-1.17B-84.0M-449.9M-1.28B-359.4M1.75M
Net income-15.7B-12.1B-21.1B-26.0B-34.6B-14.9B-8.74B-5.91B-8.45B-8.27B
Earnings per share, basic-363.37-448.70-780.84-1,208.34-1,614.66-974.22-580.91-410.30-588.42-629.13

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents10.2B864.0M5.50B764.3M1.61B1.52B2.01B151.1M1.60B651.3M
Short-term investments35.3B31.1B49.9B64.4B83.5B31.5B35.2B46.6B20.1B12.1B
Receivables772.1M1.64B468.1M898.1M731.3M841.9M1.12B1.19B146.6M54.0M
Inventory750.7M585.0M55.2M498.0M774.4M704.5M311.1M206.5M
Current assets47.6B35.3B56.9B68.8B88.6B36.1B43.1B50.4B24.8B13.2B
Property, plant and equipment9.31B9.85B5.74B5.86B3.55B2.31B1.13B1.32B1.56B
Total assets68.1B65.3B78.1B80.4B105.0B44.4B47.3B54.0B30.3B18.6B
Accounts payable1.30B1.68B470.7M863.8M1.89B1.53B931.9M591.0M
Current liabilities10.0B11.0B6.10B4.92B9.61B8.49B17.5B1.59B1.25B1.16B
Long-term debt1.06B0011.5B2.52B22.2B3.79B
Total debt11.7B2.87B22.2B3.79B
Total liabilities13.8B15.0B13.8B13.7B16.0B31.5B28.3B30.7B6.53B2.37B
Shareholders' equity57.1B50.3B63.2B66.7B89.0B12.9B19.0B23.3B23.8B16.2B
Shares outstanding43.2M27.0M27.0M21.5M21.4M15.3M15.0M14.4M14.4M13.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-5.98B-12.2B-20.1B-18.6B-30.0B-9.75B-8.32B-7.48B-6.76B-5.99B
Capital spending-1.22B-4.99B-1.67B-767.9M-2.38B-2.03B-990.9M-243.4M-272.7M-1.49B
Free cash flow-7.20B-17.2B-21.8B-19.5B-32.8B-11.8B-9.31B-7.73B-7.03B-7.48B
Cash from investing7.34B5.67B17.2B-56.7B4.45B11.1B-27.0B-8.28B616.0M
Cash from financing646.5M17.9B880.0M86.6B4.14B403.1M30.7B18.7B288.3M
Share buybacks15.0B3.41B88.2B228.6M662.0M467.0M13.1B172.5M
Change in cash8.77B-4.07B3.45B-603.2M-74.0M-1.11B3.15B-3.72B3.62B-5.08B

Open Financials

Cap table

Built by 6ix from EyeGene, Inc.’s releases

Common shares
43,222,876
Fully diluted
43,222,876

Fully diluted

LineShares
Common shares43,222,876

Share count over time

CountShares
Nov 22, 202643,222,876

Open Cap table

Shareholders

StakeFiling
한국비엠아이Large holding report (5%)

Open Shareholders

Log in to ask 6ix AI your own questions about EyeGene, Inc.